Tag: synthetic cannabinoids
Kratom to be classified as a Schedule I drug
The DEA announced that it will place the active materials from the kratom plant into Schedule I of the Controlled Substances Act.
Refining our synthetic cannabinoids panel
Our experts continually monitor and adjust our drug tests to offer a standardized panel that detects the most relevant synthetic cannabinoids.
Synthetic drugs: Common questions
Dr. Kim Samano presented information about synthetic cannabinoids ("K2/Spice") and designer stimulants known as “bath salts” in our recent webinar.
Changing perceptions of marijuana and synthetic marijuana
High school seniors' perceived risk with occasional marijuana use is declining while they increasingly view synthetic marijuana use as harmful.
Dangers of synthetic cannabinoids
Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.
New to drug testing: Synthetic stimulants
Synthetic compounds change frequently and our scientific experts must monitor, and adjust our testing panels to an ever-changing list of substances.
New to drug testing: Synthetic marijuana
In our ongoing quest to help keep workplaces drug-free, we now offer a synthetic cannabinoids panel to test for commonly detected compounds.
Quest Diagnostics tests for synthetic cannabinoids
Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.
New drug detection system finds synthetic marijuana in all populations
The CDEWS is designed to detect emerging drugs by re-testing urine specimens collected by criminal justice system drug testing programs.
Synthetic cannabinoid user profile
The first study to obtain a detailed profile of users of synthetic cannabinoid was published in the May 20 issue of the CESAR report.
